Aptus Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE15XJ01010
  • NSEID:
  • BSEID: 544529
INR
487.45
9.55 (2.0%)
BSENSE

Nov 20

BSE+NSE Vol: 8400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 89.65% vs 37.52% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 53.62% vs 213.44% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 71.21% vs 94.74% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 49.05% vs 288.37% in Mar 2025

Compare Profit and Loss Results of Aptus Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
46.00
342.00
-296.00
-86.55%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
46.00
342.00
-296.00
-86.55%
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
9.00
-15.00
-166.67%
Raw Materials Consumed
27.00
120.00
-93.00
-77.50%
Power & Fuel Cost
0.00
12.00
-12.00
-100.00%
Employee Cost
5.00
93.00
-88.00
-94.62%
Operating Expenses
0.00
29.00
-29.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
19.00
-11.00
-57.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
17.00
-17.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39.00
341.00
-302.00
-88.56%
Operating Profit (PBDIT) excl Other Income
7.00
0.00
7.00
0%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
7.00
9.00
-2.00
-22.22%
Interest
0.00
10.00
-10.00
-100.00%
Profit before Depriciation and Tax
6.00
0.00
6.00
0%
Depreciation
0.00
10.00
-10.00
-100.00%
Profit Before Taxation & Exceptional Items
6.00
-11.00
17.00
154.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-13.00
19.00
146.15%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
4.00
-14.00
18.00
128.57%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
174.00
-173.00
-99.43%
Profit Available for appropriations
5.00
160.00
-155.00
-96.88%
Appropriations
5.00
160.00
-155.00
-96.88%
Equity Dividend (%)
0%
50%
-50.00
Earnings Per Share
7.78
-1.54
9.32
605.19%
Profit And Loss - Net Sales
Net Sales 46.57 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 89.65% vs 37.52% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.45 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 53.62% vs 213.44% in Mar 2025

Profit And Loss - Interest
Interest 0.80 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 71.21% vs 94.74% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 4.62 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.05% vs 288.37% in Mar 2025